Comprehensive Cancer Center of Nevada

Henderson, Nevada 89074

0 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Carcinoma, Renal Cell, Metastatic Breast Cancer, Multiple Myeloma

Studies at this site

• A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM) — Stopped early
• A Study to Compare Tivozanib Hydrochloride to Sorafenib in Participants With Refractory Advanced Renal Cell Carcinoma (RCC) — Completed
• TAC Versus TC for Adjuvant Breast Cancer — Completed
• Phase II Trial of Weekly or Every 3-week Ixabepilone for Patients With Metastatic Breast Cancer — Completed